The strategic move is aimed at integrating automated, high-throughput gene synthesis into Regeneron's in-house laboratories.

To help address the impact of COPD on patients and communities, global healthcare companies Sanofi and Regeneron are working together to study the ripple effects of COPD and to help create a ...

Fintel reports that on May 14, 2025, Citigroup upgraded their outlook for Regeneron Pharmaceuticals (LSE:0R2M) from Neutral to Buy. There are 2,406 funds or institutions reporting positions in ...

The latest price target for Regeneron Pharmaceuticals (NASDAQ:REGN) was reported by Citigroup on May 14, 2025. The analyst firm set a price target for $700.00 expecting REGN to rise to within 12 ...

A talented learner from Luhlaza High School in Khayelitsha, Salusiwe Mxayiya is gearing up to represent her country at the esteemed Regeneron International Science and Engineering Fair (ISEF), also ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst ...

Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday.

Amazon’s Vulcan robot adds touch to automation, boosting precision and safety in warehouse tasks while reducing strain for manufacturing logistics teams Geopolitical risk, supply chain disruption, ...

It took seven years of hard work for Kareem Amin, co-founder and CEO of sales automation startup Clay, to see the company’s product finally take off in 2022. Since then, the startup has ...

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes ...